Skip to main content
. 2021 May 28;12:582447. doi: 10.3389/fphar.2021.582447

FIGURE 4.

FIGURE 4

The analysis of QOL between two groups. The pooled result showed a significant improvement in QOL in the Aidi and GP combination compared to that in the control group (OR = 3.03, 95% CI [2.55 to 3.60], p < 0.00001). Note: GP, Gemcitabine and cisplatin; QOL, quality of life.